Archive Newsletter
-
07.17.24 -- Making Cancer Vaccines Is Complex; New Platform Guidance Could Help
7/17/2024
07/17/24 Cell & Gene Newsletter
-
07.16.24 -- Maximize Bioprocessing Uptime With Comprehensive Service Solutions
7/16/2024
07/16/24 Cell & Gene Newsletter
-
07.16.24 -- Building A Universal AAV For Cancer
7/16/2024
07/16/24 Cell & Gene Newsletter
-
07.15.24 -- Ensure Success In Oncolytic Virus Manufacturing
7/15/2024
07/15/24 Cell & Gene Newsletter
-
07.15.24 -- Design And Function Of GMP Transition Spaces
7/15/2024
07/15/24 Cell & Gene Newsletter
-
07.11.24 -- CRISPR-Cas Genome Editing For Rejuvenation Of Aging Stem Cells
7/11/2024
07/11/24 Cell & Gene Newsletter
-
07.10.24 -- Inside Next-Gen Platforms For Cell Therapy Manufacturing
7/10/2024
07/10/24 Cell & Gene Newsletter
-
07.09.24 -- The Rising Tide Of Ophthalmologic Gene Therapies
7/9/2024
07/09/24 Cell & Gene Newsletter
-
07.08.24 -- The Path Forward For CLL Is Allogeneic
7/8/2024
07/08/24 Cell & Gene Newsletter
-
07.05.24 -- New Episodes Await! ADCs Ignited, mRNA Therapy for DMD, C&G Regulatory Guidance, and more.
7/5/2024
07/05/24 Cell & Gene Newsletter
This website uses cookies to ensure you get the best experience on our website. Learn more